ES2172241T3 - Comprimidos para masticar o para chupar, que comprenden hierro como principio activo. - Google Patents

Comprimidos para masticar o para chupar, que comprenden hierro como principio activo.

Info

Publication number
ES2172241T3
ES2172241T3 ES98955688T ES98955688T ES2172241T3 ES 2172241 T3 ES2172241 T3 ES 2172241T3 ES 98955688 T ES98955688 T ES 98955688T ES 98955688 T ES98955688 T ES 98955688T ES 2172241 T3 ES2172241 T3 ES 2172241T3
Authority
ES
Spain
Prior art keywords
less
polyols
cheat
suck
compressed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98955688T
Other languages
English (en)
Inventor
Catherine Meignant
Stephanie Verdier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Innothera SAS
Original Assignee
Laboratoires Innothera SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Innothera SAS filed Critical Laboratoires Innothera SAS
Application granted granted Critical
Publication of ES2172241T3 publication Critical patent/ES2172241T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Confectionery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición farmacéutica en forma galénica unitaria de comprimidos para masticar o para chupar que comprende como principio activo hierro elemento, caracterizada porque comprende: - una sal de hierro, - por lo menos dos polioles. - un agente ligante, - un agente lubrificante, y - un agente aromatizante.
ES98955688T 1998-02-03 1998-11-18 Comprimidos para masticar o para chupar, que comprenden hierro como principio activo. Expired - Lifetime ES2172241T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9801223A FR2774291B1 (fr) 1998-02-03 1998-02-03 Specialite pharmaceutique sous forme galenique unitaire de comprimes a croquer ou a sucer, comprenant comme principe actif du fer element

Publications (1)

Publication Number Publication Date
ES2172241T3 true ES2172241T3 (es) 2002-09-16

Family

ID=9522527

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98955688T Expired - Lifetime ES2172241T3 (es) 1998-02-03 1998-11-18 Comprimidos para masticar o para chupar, que comprenden hierro como principio activo.

Country Status (10)

Country Link
US (1) US6610325B1 (es)
EP (1) EP1052987B1 (es)
JP (1) JP2002502817A (es)
AT (1) ATE212836T1 (es)
AU (1) AU1244199A (es)
CA (1) CA2319011A1 (es)
DE (1) DE69803806T2 (es)
ES (1) ES2172241T3 (es)
FR (1) FR2774291B1 (es)
WO (1) WO1999039708A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000169385A (ja) * 1998-12-10 2000-06-20 Taisho Pharmaceut Co Ltd 内服液剤
JP4992162B2 (ja) * 2000-11-27 2012-08-08 大正製薬株式会社 鉄イオン配合内服液剤
US20030215498A1 (en) * 2002-05-17 2003-11-20 Harland Ronald S. Rapidly disintegrating comressed tablets comprising biologically active compounds
FR2845597B1 (fr) * 2002-10-11 2005-03-11 Innothera Lab Sa Formulation orale seche contenant de la diosmine sous forme pharmaceutique de comprime a croquer
JP5167389B2 (ja) * 2010-07-07 2013-03-21 日本たばこ産業株式会社 クエン酸第二鉄を含む錠剤
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
MX2016014281A (es) 2014-05-22 2017-02-22 Therapeuticsmd Inc Formulaciones y terapias de reemplazo de combinación de hormonas naturales.
WO2020230090A1 (en) * 2019-05-14 2020-11-19 Nokha Trading Llp Ferrous sulphate oral compositions
WO2021107835A1 (en) * 2019-11-26 2021-06-03 Double Bond Pharmaceuticals Ab Oral administration of iron succinate for use in treating iron deficiency in patients having heart failure
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409905A (en) * 1981-01-05 1995-04-25 Eby, Iii; George A. Cure for commond cold
GB2195890A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
GB2195891A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
JPH0678247B2 (ja) * 1988-10-04 1994-10-05 大塚製薬株式会社 Ｎｍｒ造影用鉄含有製剤
SU1644879A1 (ru) * 1989-04-18 1991-04-30 Одесский технологический институт пищевой промышленности им.М.В.Ломоносова Способ приготовлени гранулированного комбикорма
ES2097155T3 (es) * 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.

Also Published As

Publication number Publication date
CA2319011A1 (fr) 1999-08-12
EP1052987B1 (fr) 2002-02-06
DE69803806D1 (de) 2002-03-21
FR2774291B1 (fr) 2000-04-21
EP1052987A1 (fr) 2000-11-22
DE69803806T2 (de) 2002-08-22
AU1244199A (en) 1999-08-23
FR2774291A1 (fr) 1999-08-06
JP2002502817A (ja) 2002-01-29
US6610325B1 (en) 2003-08-26
WO1999039708A1 (fr) 1999-08-12
ATE212836T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
ES2172241T3 (es) Comprimidos para masticar o para chupar, que comprenden hierro como principio activo.
ES2156840T1 (es) Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
ES2152966T3 (es) Formas de dosificado farmaceuticas de desleido rapido y procedimiento para su preparacion.
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
BRPI0513300A (pt) forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol
ES2187822T3 (es) Comprimidos de disgregacion rapida.
AR022065A1 (es) Tabletas masticables suaves
BG102744A (bg) Дозирана лекарствена форма на ибупрофен
JO2381B1 (en) Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease
EP0509317A3 (en) Use of droloxifene in the treatment of bone diseases
MY129356A (en) Electrospun pharmaceutical compositions
IT1211484B (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
ES2148838T3 (es) Oligonucleotidos antisentido contra la subunidad reguladora alfa de la proteina quinasa dependiente de camp para el tratamiento del cancer.
UA26455C2 (uk) Лікарський препарат у формі таблеток із сповільhеhим вивільhеhhям активhого іhгредієhта
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
BG102689A (bg) Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
DE69434121D1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
NZ544645A (en) Use of calcitonin in osteoarthritis
DK0785769T3 (da) Terapeutisk vitamin-calcium-kombination i form af en galenisk enhedsdosistablet, fremgangsmåde til fremstilling af denne sa
DK0416950T3 (da) Medikamenter
YU30002A (sh) Upotreba dipiridamola ili mopidamola u pripremanju leka za lečenje i prevenciju mikrocirkulacionih poremećaja koji zavise od fibrina
ES2142388T3 (es) Agente anti-diabetico.
WO2002053090A3 (fr) Association medicamenteuse d'une biguanine (metformine) et d'arginine
CO4410176A1 (es) Formulaciones farmaceuticas de cefaclor
GB2021409A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1052987

Country of ref document: ES